BA
GILD icon

Broadview Advisors’s Gilead Sciences GILD Stock Holding History

Broadview Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,400
Closed -$727K – 100
2015
Q3 		$727K Hold
7,400
– – 0.1% 80
2015
Q2 		$866K Buy
+7,400
New +$809K 0.09% 89

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Broadview Advisors's GILD Position: Q4 2015 in Review

Broadview Advisors sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 7,400 shares — an estimated $727K sold.

Broadview Advisors first reported a position in GILD in Q2 2015 and held it in 2 quarters. The position peaked at $866K in Q2 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Broadview Advisors reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Broadview Advisors sold 7,400 Gilead Sciences shares in Q4 2015, an estimated $727K.
  • Broadview Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 2 quarters.
  • Broadview Advisors's Gilead Sciences position peaked at $866K in Q2 2015.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Broadview Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.